Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival

  • Jung Kim
  • , Zalman Vaksman
  • , Laura E. Egolf
  • , Rebecca Kaufman
  • , J. Perry Evans
  • , Karina L. Conkrite
  • , Arnavaz Danesh
  • , Gonzalo Lopez
  • , Michael P. Randall
  • , Maiah H. Dent
  • , Lance M. Farra
  • , Neil L. Menghani
  • , Malwina Dymek
  • , Heena Desai
  • , Ryan Hausler
  • , Belynda Hicks
  • , Jaime Guidry Auvil
  • , Daniela S. Gerhard
  • , Hakon Hakonarson
  • , Kara N. Maxwell
    • Kristina A. Cole, Trevor J. Pugh, Kristopher R. Bosse, Javed Khan, Jun S. Wei, John M. Maris, Douglas R. Stewart, Sharon J. Diskin

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology